The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-((1S)-1-{[((1S)-3-Hydroxy-2-oxo-1-{[(3S)-2-oxopyrrolidin-3-yl]-methyl}propyl)amino]carbonyl}pentyl)-4-methoxy-1H-indole-2-carboxamide ID: ALA4754028
PubChem CID: 154702364
Max Phase: Preclinical
Molecular Formula: C24H32N4O6
Molecular Weight: 472.54
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCCC[C@H](NC(=O)c1cc2c(OC)cccc2[nH]1)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)CO
Standard InChI: InChI=1S/C24H32N4O6/c1-3-4-6-17(23(32)28-18(20(30)13-29)11-14-9-10-25-22(14)31)27-24(33)19-12-15-16(26-19)7-5-8-21(15)34-2/h5,7-8,12,14,17-18,26,29H,3-4,6,9-11,13H2,1-2H3,(H,25,31)(H,27,33)(H,28,32)/t14-,17-,18-/m0/s1
Standard InChI Key: VBDNWOQWUMJPAC-WBAXXEDZSA-N
Molfile:
RDKit 2D
35 37 0 0 0 0 0 0 0 0999 V2000
18.2948 -7.4780 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7117 -8.1874 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.7033 -6.7638 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.5247 -6.7589 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9291 -6.0447 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9374 -7.4684 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7587 -7.4635 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1756 -8.1729 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7504 -6.0399 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.5163 -5.3353 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.1589 -5.3257 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9802 -5.3208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.3846 -4.6066 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.3930 -6.0302 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.7420 -4.6162 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1505 -3.9020 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9642 -3.8147 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1294 -3.0102 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4151 -2.6058 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.8071 -3.1563 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0022 -2.9929 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.3266 -3.8961 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
23.2059 -4.6018 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.4735 -7.4828 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9887 -6.8240 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9965 -8.1528 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.2139 -7.9038 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2130 -7.0843 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5040 -6.6770 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7954 -7.0882 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8002 -7.9108 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5098 -8.3143 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5022 -5.8599 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.7936 -5.4528 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9928 -8.1667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
1 3 1 0
3 4 1 0
4 5 1 0
4 6 1 6
6 7 1 0
7 8 1 0
5 9 1 0
5 10 2 0
9 11 1 0
11 12 1 0
12 13 1 0
12 14 2 0
11 15 1 1
15 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 16 1 0
20 21 2 0
16 22 1 6
13 23 1 0
1 24 1 0
24 25 2 0
25 28 1 0
27 26 1 0
26 24 1 0
27 28 2 0
28 29 1 0
29 30 2 0
30 31 1 0
31 32 2 0
32 27 1 0
29 33 1 0
33 34 1 0
8 35 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 472.54Molecular Weight (Monoisotopic): 472.2322AlogP: 1.04#Rotatable Bonds: 12Polar Surface Area: 149.62Molecular Species: NEUTRALHBA: 6HBD: 5#RO5 Violations: ┄HBA (Lipinski): 10HBD (Lipinski): 5#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.46CX Basic pKa: ┄CX LogP: 0.48CX LogD: 0.48Aromatic Rings: 2Heavy Atoms: 34QED Weighted: 0.31Np Likeness Score: 0.30
References 1. Hoffman RL,Kania RS,Brothers MA,Davies JF,Ferre RA,Gajiwala KS,He M,Hogan RJ,Kozminski K,Li LY,Lockner JW,Lou J,Marra MT,Mitchell LJ,Murray BW,Nieman JA,Noell S,Planken SP,Rowe T,Ryan K,Smith GJ,Solowiej JE,Steppan CM,Taggart B. (2020) Discovery of Ketone-Based Covalent Inhibitors of Coronavirus 3CL Proteases for the Potential Therapeutic Treatment of COVID-19., 63 (21): [PMID:33054210 ] [10.1021/acs.jmedchem.0c01063 ]